BRNS
Barinthus Biotherapeutics plc.Company with tickers: BRNS
CIK
1828185
CUSIP
91864C107
Shares Outstanding
40,848,893
13F Activity (30d)
14 filings
12 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | Swirsky Douglas J |
Director | Other | 0 |
| 2025-06-10 | Wright Robin |
Director | Award | 20,174 |
| 2025-06-10 | Hammacher Alex |
Director | Award | 20,174 |
| 2025-06-10 | Phillips Anne M. |
Director | Award | 20,174 |
| 2025-06-10 | Morgon Pierre A. |
Director | Award | 20,174 |
| 2025-06-10 | DAWES KAREN A |
Director | Award | 20,174 |
| 2025-06-10 | Scheeren Joseph |
Director | Award | 20,174 |
| 2025-02-03 | Enright William |
Director | Award | 600,000 |
| 2025-02-03 | Griffiths Graham |
Chief Business Officer | Award | 200,000 |
| 2025-02-03 | Hooftman Leon |
Chief Medical Officer | Award | 140,000 |
| 2025-02-03 | Brown Gemma |
Chief Financial Officer | Award | 160,000 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 1,310 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 0 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 0 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 0 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 0 |
| 2024-12-17 | Lynn Geoffrey |
Chief Scientific Officer | Other | 638,442 |
| 2024-06-03 | Hooftman Leon |
Chief Medical Officer | Award | 195,166 |
| 2024-06-03 | Hooftman Leon |
Chief Medical Officer | Other | 0 |
| 2024-05-10 | Wright Robin |
Director | Award | 19,516 |
| 2024-05-10 | DAWES KAREN A |
Director | Award | 19,516 |
| 2024-05-10 | Scheeren Joseph |
Director | Award | 19,516 |
| 2024-05-10 | Morgon Pierre A. |
Director | Award | 19,516 |
| 2024-05-10 | Hammacher Alex |
Director | Award | 19,516 |
| 2024-05-10 | Phillips Anne M. |
Director | Award | 19,516 |
| 2024-01-02 | Brown Gemma |
Chief Financial Officer | Award | 193,000 |
| 2024-01-02 | Enright William |
Director | Award | 443,981 |
| 2024-01-02 | Pelletier Nadege |
Chief Scientific Officer | Award | 105,000 |
| 2024-01-02 | Griffiths Graham |
Chief Business Officer | Award | 96,500 |
| 2023-06-26 | Scheeren Joseph |
Director | Buy | 10,000 |
| 2023-05-25 | Wright Robin |
Director | Buy | 13,750 |
| 2023-05-11 | DAWES KAREN A |
Director | Award | 19,197 |
| 2023-05-11 | Wright Robin |
Director | Award | 19,197 |
| 2023-05-11 | Phillips Anne M. |
Director | Award | 19,197 |
| 2023-05-11 | Morgon Pierre A. |
Director | Award | 19,197 |
| 2023-05-11 | Hammacher Alex |
Director | Award | 19,197 |
| 2023-05-11 | Scheeren Joseph |
Director | Award | 19,197 |
| 2023-03-27 | Enright William |
Director | Other | 514,923 |
| 2023-03-27 | Enright William |
Director | Sell | 15,000 |
| 2023-02-01 | Pelletier Nadege |
Chief Scientific Officer | Award | 485,000 |
| 2023-01-30 | Pelletier Nadege |
Chief Scientific Officer | Other | 0 |
| 2023-01-03 | Ellis Christopher |
Chief Operating Officer | Award | 105,000 |
| 2023-01-03 | Marshall Margaret |
Chief Medical Officer | Award | 60,000 |
| 2023-01-03 | Griffiths Graham |
Chief Business Officer | Award | 105,000 |
| 2023-01-03 | Enright William |
Director | Award | 440,000 |
| 2023-01-03 | Brown Gemma |
Chief Financial Officer | Award | 33,100 |
| 2023-01-03 | Evans Thomas George |
Fmr Chief Scientific Officer | Award | 125,000 |
| 2022-09-30 | M&G Alternatives Investment Management Ltd |
10% Owner | Other | 4,108,752 |
| 2022-09-30 | M&G INVESTMENT MANAGEMENT LTD |
10% Owner | Other | 4,108,752 |
| 2022-09-26 | Brown Gemma |
Chief Financial Officer | Award | 334,000 |
Showing 1–50 of 162 transactions